Follow
Zhuoran Zhang
Zhuoran Zhang
Post-doctoral Fellow, Beckman Research Institute, City of Hope National Cancer Center
Verified email at coh.org
Title
Cited by
Cited by
Year
Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo
YL Su, X Wang, M Mann, TP Adamus, D Wang, DF Moreira, Z Zhang, ...
Blood 135 (3), 167-180, 2020
982020
STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
D Moreira, T Adamus, X Zhao, YL Su, Z Zhang, SV White, P Swiderski, ...
Clinical Cancer Research 24 (23), 5948-5962, 2018
792018
Adoptive transfer of phosphoantigen-specific γδ T cell subset attenuates mycobacterium tuberculosis infection in nonhuman primates
A Qaqish, D Huang, CY Chen, Z Zhang, R Wang, S Li, E Yang, Y Lu, ...
The Journal of Immunology 198 (12), 4753-4763, 2017
742017
Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates
L Shen, J Frencher, D Huang, W Wang, E Yang, CY Chen, Z Zhang, ...
Proceedings of the National Academy of Sciences 116 (13), 6371-6378, 2019
722019
Pathogenic events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis
L Shen, CY Chen, D Huang, R Wang, M Zhang, L Qian, Y Zhu, AZ Zhang, ...
Journal of virology 91 (14), e02310-16, 2017
442017
B cell lymphoma immunotherapy using TLR9-targeted oligonucleotide STAT3 inhibitors
X Zhao, Z Zhang, D Moreira, YL Su, H Won, T Adamus, Z Dong, Y Liang, ...
Molecular Therapy 26 (3), 695-707, 2018
292018
Cell-based high-throughput screening assay identifies 2′, 2′-difluoro-2′-deoxycytidine gemcitabine as a potential antipoliovirus agent
Z Zhang, E Yang, C Hu, H Cheng, CY Chen, D Huang, R Wang, Y Zhao, ...
ACS infectious diseases 3 (1), 45-53, 2017
232017
Anti-tuberculosis (TB) chemotherapy dynamically rescues Th1 and CD8+ T effector levels in Han Chinese pulmonary TB patients
G Li, F Yang, X He, Z Liu, J Pi, Y Zhu, X Ke, S Liu, M Ou, H Guo, Z Zhang, ...
Microbes and infection 22 (3), 119-126, 2020
142020
Multidrug-resistant tuberculosis (MDR-TB) strain infection in macaques results in high bacilli burdens in airways, driving broad innate/adaptive immune responses
E Yang, R Yang, M Guo, D Huang, W Wang, Z Zhang, C Chen, F Wang, ...
Emerging microbes & infections 7 (1), 1-12, 2018
142018
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors
G Garrido, B Schrand, A Levay, A Rabasa, A Ferrantella, DM Da Silva, ...
Cancer immunology research 8 (7), 856-868, 2020
112020
Pre-transplant cytoreductive therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood stem cell …
Q Wang, X Zhao, Z Liu, X Zhao, G Zhang, J Yao, X Zheng, L Zhang, ...
American Journal of Cancer Research 10 (4), 1218, 2020
92020
Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy
Z Zhang, X Zhao, D Wang, D Moreira, YL Su, M Alcantara, P Swiderski, ...
Molecular Therapy 29 (3), 1214-1225, 2021
52021
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
J Hall, Z Zhang, S Bhattacharya, D Wang, M Alcantara, Y Liang, ...
Molecular Therapy-Nucleic Acids, 2024
22024
Targeted Delivery of CpG-Mir-146a Mimic Oligonucleotides As a Therapeutic Strategy to Reduce NF-Κb-Mediated Pathogenic Inflammation and Myeloid Leukemia Progression
SU Yu-Lin, Z Zhang, M Mann, X Wang, B Zhang, L Li, P Swiderski, ...
Blood 132, 3501, 2018
22018
Targeted Delivery of miR-146a Mimic Oligonucleotides as a Potential Therapeutic Approach to Modulate NF-kB Signaling in Myeloid Leukemia and Myeloproliferative Diseases
Y Su, Z Zhang, P Swiderski, D Zeng, G Marcucci, M Boldin, M Kortylewski
Experimental Hematology 64, S42, 2018
22018
Targeted in vivo delivery of NF-κB decoy oligodeoxynucleotide augments efficacy of radiation therapy against B-cell lymphomas
Z Zhang, X Zhao, D Moreira, YL Su, P Swiderski, S Forman, L Kwak, ...
Cancer Research 80 (16_Supplement), 5356-5356, 2020
12020
Bow-tie architectures in biological and artificial neural networks: implications for network evolution and assay design
S Hilliard, K Mosoyan, S Branciamore, G Gogoshin, A Zhang, DL Simons, ...
iScience, 2023
2023
Oligo-Protac Strategy for Cell-Selective and Targeted Degradation of Activated Stat3
J Hall, Z Zhang, S Bhattacharya, D Wang, Y Liang, P Swiderski, N Vaidehi, ...
MOLECULAR THERAPY 30 (4), 105-105, 2022
2022
Targeted RNA therapeutics for treatment of cancer and immunomodulation
Z Zhang, YL Su, C Yu, M Alcantara, D Rossi, M Kortylewski
RNA Therapeutics, 37-55, 2022
2022
Myeloid cell-targeted miR-146a mimic alleviates NF-κB-driven cytokine storm without interfering with CD19-specific CAR T cell activity against B cell lymphoma
M Kortylewski, YL Su, X Wang, M Mann, D Moreira, Z Zhang, C Ouyang, ...
Journal for ImmunoTherapy of Cancer 7 (S1), Art. No. O61, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20